menu
    • menu

    Company profile for Alumis

    NEW Drugs in Dev: 3
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alumis is dedicated to transforming the lives of patients grappling with immune diseases through a precision-oriented approach. Our objective is to enhance patient lives substantially by replacing broad immunosuppression with targeted therapies. Our existence is centered around addressing the specific needs of these patients. We are at the forefront of pioneering a precision approach that utilizes insights derived from powerfu...
    Alumis is dedicated to transforming the lives of patients grappling with immune diseases through a precision-oriented approach. Our objective is to enhance patient lives substantially by replacing broad immunosuppression with targeted therapies. Our existence is centered around addressing the specific needs of these patients. We are at the forefront of pioneering a precision approach that utilizes insights derived from powerful data analytics to select the right target, molecule, indication, patient, and endpoint, ultimately optimizing outcomes for patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AlumisUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    611 Gateway Blvd, Suite 820, South San Francisco, California 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alumis.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alumis-co/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/_Alumis

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alumis Closes Upsized Offering as Underwriters Exercise Full
    Alumis Closes Upsized Offering as Underwriters Exercise Full

    09 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/09/3216342/0/en/Alumis-Announces-Closing-of-Upsized-Public-Offering-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html

    GLOBENEWSWIRE
    09 Jan 2026
    Share Share
    Alumis Announces Proposed Public Offering Of Common Stock
    Alumis Announces Proposed Public Offering Of Common Stock

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3214139/0/en/Alumis-Announces-Proposed-Public-Offering-of-Common-Stock.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Alumis Reports Phase 3 ONWARD Data for Envudeucitinib in Plaque
    Alumis Reports Phase 3 ONWARD Data for Envudeucitinib in Plaque

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3213244/0/en/Alumis-to-Host-Conference-Call-and-Webcast-to-Report-Phase-3-ONWARD-Topline-Data-for-Envudeucitinib-in-Moderate-to-Severe-Plaque-Psoriasis.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Alumis Reports Q3 2025 Financial Results And Recent Advances
    Alumis Reports Q3 2025 Financial Results And Recent Advances

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187873/0/en/Alumis-Reports-Third-Quarter-2025-Financial-Results-and-Highlights-Recent-Progress.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Alumis To Participate In Upcoming November Investor Conferences
    Alumis To Participate In Upcoming November Investor Conferences

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180248/0/en/Alumis-to-Participate-in-Upcoming-November-Investor-Conferences.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share
    Alumis to Participate in Upcoming September Investor Conferences
    Alumis to Participate in Upcoming September Investor Conferences

    29 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/29/3141412/0/en/Alumis-to-Participate-in-Upcoming-September-Investor-Conferences.html

    GLOBENEWSWIRE
    29 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search